Tempest Therapeutics, Inc. (OVAS) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues	0.0	0.0	0.0	90.8	53.7	0.3	0.7	0.3
Revenue growth			-100.0%	68.9%	18119.7%	-54.8%	135.7%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.8	5.4	2.2
Gross profit	0.0	0.0	0.0	90.8	53.7	-0.5	-4.7	-2.0
Gross margin				100.0%	100.0%	-167.8%	-727.1%	-711.9%
Selling, general and administrative [+]	12.1	9.8	4.9	17.6	8.7	27.7	49.2	51.6
General and administrative	12.1	9.8	4.9	17.6	8.7
Research and development	22.5	17.2	14.4	27.8	14.4	18.3	21.6	18.4
Equity in earnings						-1.0	-1.5	-1.6
Other operating expenses					3.8
EBITDA [+]	-34.0	-26.6	-19.0	45.5	26.9	-45.9	-74.9	-72.3
EBITDA growth	27.8%	40.4%	-141.7%	69.1%	-158.6%	-38.7%	3.7%	47.3%
EBITDA margin				50.1%	50.1%	-15574.2%	-11472.6%	-26091.7%
Depreciation and amortization	0.6	0.4	0.3	0.1	0.0	1.7	2.2	1.3
EBIT [+]	-34.6	-27.0	-19.3	45.4	26.9	-47.6	-77.2	-73.6
EBIT growth	28.4%	39.8%	-142.5%	68.9%	-156.5%	-38.3%	4.9%	48.6%
EBIT margin				50.0%	50.0%	-16133.6%	-11815.3%	-26556.0%
Non-recurring items						4.0	5.4
Interest expense, net [+]	1.6	1.3		-1.0	-0.1	-0.8	-0.7	-0.4
Interest expense	1.6	1.3			0.2
Interest income				1.0	0.1	0.8	0.7	0.4
Other income (expense), net [+]	0.5	0.0	0.1	-91.0	-54.0	0.0	-0.2	0.0
Other non-operating gains/losses				0.2	0.2
Other	0.5	0.0	0.1	0.2	0.2	0.0	-0.2	0.0
Pre-tax income	-35.7	-28.3	-19.2	-44.6	-27.2	-50.9	-82.1	-73.1
Income taxes	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1
Tax rate	0.0%	0.0%	0.0%	0.0%
Minority interest					0.0
Net income	-35.7	-28.3	-19.2	-44.6	-27.2	-51.0	-82.3	-73.2
Net margin				-49.1%	-50.6%	-17279.7%	-12597.2%	-26432.9%

Basic EPS [+]	($3.09)	($7.47)	($41.03)	($3.25)	($17.58)	($1.43)	($2.56)	($2.70)
Growth	-58.6%	-81.8%	1161.8%	-81.5%	1130.1%	-44.2%	-5.3%	23.6%
Diluted EPS [+]	($3.09)	($7.47)	($41.03)	($3.25)	($17.58)	($1.43)	($2.56)	($2.70)
Growth	-58.6%	-81.8%	1161.8%	-81.5%	1130.1%	-44.2%	-5.3%	23.6%

Shares outstanding (basic) [+]	11.5	3.8	0.5	13.7	1.5	35.7	32.1	27.1
Growth	204.7%	709.6%	-96.6%	786.0%	-95.7%	11.0%	18.7%	19.6%
Shares outstanding (diluted) [+]	11.5	3.8	0.5	13.7	1.5	35.7	32.1	27.1
Growth	204.7%	709.6%	-96.6%	786.0%	-95.7%	11.0%	18.7%	19.6%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.